𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes

✍ Scribed by Hesham M. Elgouhari; Hari S. Conjeevaram

Book ID
107540484
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
332 KB
Volume
7
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Race, insulin resistance and hepatic ste
Race, insulin resistance and hepatic steatosis in chronic hepatitis C
✍ Hari S. Conjeevaram; David E. Kleiner; Jay E. Everhart; Jay H. Hoofnagle; Steven πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

Hepatic steatosis is common in chronic hepatitis C and has been linked to concurrent obesity, insulin resistance, diabetes, disease severity, and poor response to therapy. Racial differences in rates of obesity and diabetes may contribute to racial differences in hepatic steatosis and treatment resp

Impact of obesity on treatment of chroni
Impact of obesity on treatment of chronic hepatitis C
✍ Michael R. Charlton; Paul J. Pockros; Stephen A. Harrison πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 288 KB

Obesity and the metabolic syndrome have hepatic manifestations, including steatosis and progression of fibrosis. In individuals with chronic hepatitis C, obesity is associated with inflammation, insulin resistance, steatosis, progression of fibrosis, and nonresponse to treatment with interferon or p